The Study on the Treatment of the Malignant Tumor of Digestive Tract with ¹³¹I一CL₃ in Tratumoral Injection Alone or Combined with LAK/IL-2 Intravenous Injection

Purpose:To explore the affection of the LAK/IL-2 intavenous injection(LAK/IL-2 IV) to the therapeutic cfficay of the radioimmunothcrapy .Method:There were 72 patients with malignant tumor of digestive tract in this study, 21 patients recepting ¹³¹I-CL₃ intratumoral injection alone(¹³¹I一CL₃ IT)，33 patients recepting LAK/IL一2 IV alone, and 18 patient recepting ¹³¹I一IL₃ IT conbined with LAK/IL一2IV. Result:The therapeutic efficay of ¹³¹I一CL₃ IT alone or LAK/IL一2 IV alone. Conclusion:LAK/IL-2 IV can enhance the therapeutic efFicay of raclicoimmunotherapy.